A similar expression pattern was observed in prostate cancer cell lines, with TDO2 being more highly expressed in the advanced CRPC prostate cancer cell lines DU145 and PC3 (Fig. 3e; Supplementary Fig. S10b). Here, TDO2 is linked to prostate carcinoma.